Evidence map›Paper›PMID 33123599›Full record

ReviewJournal of diabetes research2020

The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy.

Raffaele Galiero, Pia Clara Pafundi, Riccardo Nevola, Luca Rinaldi, Carlo Acierno, Alfredo Caturano, Teresa Salvatore, Luigi Elio Adinolfi, Ciro Costagliola, Ferdinando Carlo Sasso

Open access · goldAbstract readReview
In one paragraph

Review in Journal of diabetes research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 5 pooled it
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 5 syntheses or guidelines pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Epigenetic Mechanisms in Type 2 Diabetes Retinopathy: A Systematic Review.International journal of molecular sciences · 2021
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Raffaele GalieroDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Luigi Miraglia 80138 Naples, Italy.ORCID https://orcid.org/0000-0002-7766-3430
Pia Clara PafundiDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Luigi Miraglia 80138 Naples, Italy.ORCID https://orcid.org/0000-0002-0310-3529
Riccardo NevolaDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Luigi Miraglia 80138 Naples, Italy.ORCID https://orcid.org/0000-0003-3320-3878
Luca RinaldiDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Luigi Miraglia 80138 Naples, Italy.ORCID https://orcid.org/0000-0002-6541-3821
Carlo AciernoDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Luigi Miraglia 80138 Naples, Italy.ORCID https://orcid.org/0000-0002-1239-7012
Alfredo CaturanoDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Luigi Miraglia 80138 Naples, Italy.ORCID https://orcid.org/0000-0001-7761-7533
Teresa SalvatoreDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Via de Crecchio 7, 80138 Naples, Italy.ORCID https://orcid.org/0000-0002-6532-7122
Luigi Elio AdinolfiDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Luigi Miraglia 80138 Naples, Italy.ORCID https://orcid.org/0000-0001-8453-4912
Ciro CostagliolaDepartment of Medicine & Health Sciences "V. Tiberio", University of Molise, Via F. De Sanctis, 1, 86100 Campobasso, Italy.ORCID https://orcid.org/0000-0001-8477-6188
Ferdinando Carlo SassoDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Luigi Miraglia 80138 Naples, Italy.ORCID https://orcid.org/0000-0002-9142-7848
University of Campania "Luigi Vanvitelli" · ITUniversity of Molise · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, telemedicine has become remarkably important, due to increased deployment and development of digital technologies. National and international guidelines should consider its inclusion in their updates. During the COVID-19 pandemic, mandatory social distancing and the lack of effective treatments has made telemedicine the safest interactive system between patients, both infected and uninfected, and clinicians. A few potential evidence-based scenarios for the application of telemedicine have been hypothesized. In particular, its use in diabetes and complication monitoring has been remarkably increasing, due to the high risk of poor prognosis. New evidence and technological improvements in telemedicine application in diabetic retinopathy (DR) have demonstrated efficacy and usefulness in screening. Moreover, despite an initial increase for devices and training costs, teleophthalmology demonstrated a good cost-to-efficacy ratio; however, no national screening program has yet focused on DR prevention and diagnosis. Lack of data during the COVID-19 pandemic strongly limits the possibility of tracing the real management of the disease, which is only conceivable from past evidence in normal conditions. The pandemic further stressed the importance of remote monitoring. However, the deployment of device and digital application used to increase screening of individuals and monitor progression of retinal disease needs to be easily accessible to general practitioners.

Indexed as

PandemicsTelemedicineBetacoronavirusCoronavirus InfectionsCost-Benefit AnalysisCOVID-19Diabetic RetinopathyHumansMass ScreeningOphthalmologyPneumonia, ViralSARS-CoV-2

Identifiers

PMID33123599
PMCPMC7584941
OpenAlexW3095003311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.